GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹466 Cr | ₹176 Cr | ₹255 Cr | ₹283 Cr | ₹366 Cr |
What is the latest Total Non-Current Liabilities ratio of GRANULES INDIA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹466 Cr |
Mar2024 | ₹176 Cr |
Mar2023 | ₹255 Cr |
Mar2022 | ₹283 Cr |
Mar2021 | ₹366 Cr |
How is Total Non-Current Liabilities of GRANULES INDIA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹466 Cr | 164.71 | |
Mar2024 | ₹176 Cr | -30.89 | |
Mar2023 | ₹255 Cr | -9.94 | |
Mar2022 | ₹283 Cr | -22.79 | |
Mar2021 | ₹366 Cr | - |
Compare Total Non-Current Liabilities of peers of GRANULES INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GRANULES INDIA | ₹12,971.1 Cr | 2.8% | 17.4% | -24.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,126.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
GRANULES INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GRANULES INDIA | 2.8% |
17.4% |
-24.1% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses